Characterization of the Small Bowel Microbiome Reveals Different Profiles in Human Subjects Who Are Overweight or Have Obesity

INTRODUCTION:Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.METHODS:Duodenal aspirates and serum samples were obtained from subjects...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of gastroenterology Vol. 119; no. 6; pp. 1141 - 1153
Main Authors Leite, Gabriela, Barlow, Gillian M., Rashid, Mohamad, Hosseini, Ava, Cohrs, Daniel, Parodi, Gonzalo, Morales, Walter, Weitsman, Stacy, Rezaie, Ali, Pimentel, Mark, Mathur, Ruchi
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Wolters Kluwer 01.06.2024
Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Subjects
Online AccessGet full text

Cover

Loading…
Abstract INTRODUCTION:Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.METHODS:Duodenal aspirates and serum samples were obtained from subjects undergoing standard-of-care esophagogastroduodenoscopy without colon preparation. Aspirate DNAs were analyzed by 16S rRNA and shotgun sequencing. Predicted microbial metabolic functions and serum levels of metabolic and inflammatory biomarkers were also assessed.RESULTS:Subjects with normal weight (N = 105), overweight (N = 67), and obesity (N = 42) were identified. Overweight-specific duodenal microbial features include lower relative abundance (RA) of Bifidobacterium species and Escherichia coli strain K-12 and higher Lactobacillus intestinalis, L. johnsonii, and Prevotella loescheii RA. Obesity-specific features include higher Lactobacillus gasseri RA and lower L. reuteri (subspecies rodentium), Alloprevotella rava, and Leptotrichia spp RA. Escalation features (progressive changes from normal weight through obesity) include decreasing Bacteroides pyogenes, Staphylococcus hominis, and unknown Faecalibacterium species RA, increasing RA of unknown Lactobacillus and Mycobacterium species, and decreasing microbial potential for biogenic amines metabolism. De-escalation features (direction of change altered in normal to overweight and overweight to obesity) include Lactobacillus acidophilus, L. hominis, L. iners, and Bifidobacterium dentium. An unknown Lactobacillus species is associated with type IIa dyslipidemia and overweight, whereas Alloprevotella rava is associated with type IIb and IV dyslipidemias.DISCUSSION:Direct analysis of the duodenal microbiome has identified key genera associated with overweight and obesity, including some previously identified in stool, e.g., Bifidobacterium and Lactobacillus. Specific species and strains exhibit differing associations with overweight and obesity, including escalation and de-escalation features that may represent targets for future study and therapeutics.
AbstractList Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity. Duodenal aspirates and serum samples were obtained from subjects undergoing standard-of-care esophagogastroduodenoscopy without colon preparation. Aspirate DNAs were analyzed by 16S rRNA and shotgun sequencing. Predicted microbial metabolic functions and serum levels of metabolic and inflammatory biomarkers were also assessed. Subjects with normal weight (N = 105), overweight (N = 67), and obesity (N = 42) were identified. Overweight-specific duodenal microbial features include lower relative abundance (RA) of Bifidobacterium species and Escherichia coli strain K-12 and higher Lactobacillus intestinalis , L. johnsonii , and Prevotella loescheii RA. Obesity-specific features include higher Lactobacillus gasseri RA and lower L. reuteri (subspecies rodentium ), Alloprevotella rava , and Leptotrichia spp RA. Escalation features (progressive changes from normal weight through obesity) include decreasing Bacteroides pyogenes , Staphylococcus hominis , and unknown Faecalibacterium species RA, increasing RA of unknown Lactobacillus and Mycobacterium species, and decreasing microbial potential for biogenic amines metabolism. De-escalation features (direction of change altered in normal to overweight and overweight to obesity) include Lactobacillus acidophilus , L. hominis , L. iners , and Bifidobacterium dentium . An unknown Lactobacillus species is associated with type IIa dyslipidemia and overweight, whereas Alloprevotella rava is associated with type IIb and IV dyslipidemias. Direct analysis of the duodenal microbiome has identified key genera associated with overweight and obesity, including some previously identified in stool, e.g., Bifidobacterium and Lactobacillus . Specific species and strains exhibit differing associations with overweight and obesity, including escalation and de-escalation features that may represent targets for future study and therapeutics.
Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.INTRODUCTIONGut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.Duodenal aspirates and serum samples were obtained from subjects undergoing standard-of-care esophagogastroduodenoscopy without colon preparation. Aspirate DNAs were analyzed by 16S rRNA and shotgun sequencing. Predicted microbial metabolic functions and serum levels of metabolic and inflammatory biomarkers were also assessed.METHODSDuodenal aspirates and serum samples were obtained from subjects undergoing standard-of-care esophagogastroduodenoscopy without colon preparation. Aspirate DNAs were analyzed by 16S rRNA and shotgun sequencing. Predicted microbial metabolic functions and serum levels of metabolic and inflammatory biomarkers were also assessed.Subjects with normal weight (N = 105), overweight (N = 67), and obesity (N = 42) were identified. Overweight-specific duodenal microbial features include lower relative abundance (RA) of Bifidobacterium species and Escherichia coli strain K-12 and higher Lactobacillus intestinalis , L. johnsonii , and Prevotella loescheii RA. Obesity-specific features include higher Lactobacillus gasseri RA and lower L. reuteri (subspecies rodentium ), Alloprevotella rava , and Leptotrichia spp RA. Escalation features (progressive changes from normal weight through obesity) include decreasing Bacteroides pyogenes , Staphylococcus hominis , and unknown Faecalibacterium species RA, increasing RA of unknown Lactobacillus and Mycobacterium species, and decreasing microbial potential for biogenic amines metabolism. De-escalation features (direction of change altered in normal to overweight and overweight to obesity) include Lactobacillus acidophilus , L. hominis , L. iners , and Bifidobacterium dentium . An unknown Lactobacillus species is associated with type IIa dyslipidemia and overweight, whereas Alloprevotella rava is associated with type IIb and IV dyslipidemias.RESULTSSubjects with normal weight (N = 105), overweight (N = 67), and obesity (N = 42) were identified. Overweight-specific duodenal microbial features include lower relative abundance (RA) of Bifidobacterium species and Escherichia coli strain K-12 and higher Lactobacillus intestinalis , L. johnsonii , and Prevotella loescheii RA. Obesity-specific features include higher Lactobacillus gasseri RA and lower L. reuteri (subspecies rodentium ), Alloprevotella rava , and Leptotrichia spp RA. Escalation features (progressive changes from normal weight through obesity) include decreasing Bacteroides pyogenes , Staphylococcus hominis , and unknown Faecalibacterium species RA, increasing RA of unknown Lactobacillus and Mycobacterium species, and decreasing microbial potential for biogenic amines metabolism. De-escalation features (direction of change altered in normal to overweight and overweight to obesity) include Lactobacillus acidophilus , L. hominis , L. iners , and Bifidobacterium dentium . An unknown Lactobacillus species is associated with type IIa dyslipidemia and overweight, whereas Alloprevotella rava is associated with type IIb and IV dyslipidemias.Direct analysis of the duodenal microbiome has identified key genera associated with overweight and obesity, including some previously identified in stool, e.g., Bifidobacterium and Lactobacillus . Specific species and strains exhibit differing associations with overweight and obesity, including escalation and de-escalation features that may represent targets for future study and therapeutics.DISCUSSIONDirect analysis of the duodenal microbiome has identified key genera associated with overweight and obesity, including some previously identified in stool, e.g., Bifidobacterium and Lactobacillus . Specific species and strains exhibit differing associations with overweight and obesity, including escalation and de-escalation features that may represent targets for future study and therapeutics.
INTRODUCTION:Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.METHODS:Duodenal aspirates and serum samples were obtained from subjects undergoing standard-of-care esophagogastroduodenoscopy without colon preparation. Aspirate DNAs were analyzed by 16S rRNA and shotgun sequencing. Predicted microbial metabolic functions and serum levels of metabolic and inflammatory biomarkers were also assessed.RESULTS:Subjects with normal weight (N = 105), overweight (N = 67), and obesity (N = 42) were identified. Overweight-specific duodenal microbial features include lower relative abundance (RA) of Bifidobacterium species and Escherichia coli strain K-12 and higher Lactobacillus intestinalis, L. johnsonii, and Prevotella loescheii RA. Obesity-specific features include higher Lactobacillus gasseri RA and lower L. reuteri (subspecies rodentium), Alloprevotella rava, and Leptotrichia spp RA. Escalation features (progressive changes from normal weight through obesity) include decreasing Bacteroides pyogenes, Staphylococcus hominis, and unknown Faecalibacterium species RA, increasing RA of unknown Lactobacillus and Mycobacterium species, and decreasing microbial potential for biogenic amines metabolism. De-escalation features (direction of change altered in normal to overweight and overweight to obesity) include Lactobacillus acidophilus, L. hominis, L. iners, and Bifidobacterium dentium. An unknown Lactobacillus species is associated with type IIa dyslipidemia and overweight, whereas Alloprevotella rava is associated with type IIb and IV dyslipidemias.DISCUSSION:Direct analysis of the duodenal microbiome has identified key genera associated with overweight and obesity, including some previously identified in stool, e.g., Bifidobacterium and Lactobacillus. Specific species and strains exhibit differing associations with overweight and obesity, including escalation and de-escalation features that may represent targets for future study and therapeutics.
INTRODUCTION:Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers in subjects with normal weight, overweight, and obesity.METHODS:Duodenal aspirates and serum samples were obtained from subjects undergoing standard-of-care esophagogastroduodenoscopy without colon preparation. Aspirate DNAs were analyzed by 16S rRNA and shotgun sequencing. Predicted microbial metabolic functions and serum levels of metabolic and inflammatory biomarkers were also assessed.RESULTS:Subjects with normal weight (N = 105), overweight (N = 67), and obesity (N = 42) were identified. Overweight-specific duodenal microbial features include lower relative abundance (RA) of Bifidobacterium species and Escherichia coli strain K-12 and higher Lactobacillus intestinalis, L. johnsonii, and Prevotella loescheii RA. Obesity-specific features include higher Lactobacillus gasseri RA and lower L. reuteri (subspecies rodentium), Alloprevotella rava, and Leptotrichia spp RA. Escalation features (progressive changes from normal weight through obesity) include decreasing Bacteroides pyogenes, Staphylococcus hominis, and unknown Faecalibacterium species RA, increasing RA of unknown Lactobacillus and Mycobacterium species, and decreasing microbial potential for biogenic amines metabolism. De-escalation features (direction of change altered in normal to overweight and overweight to obesity) include Lactobacillus acidophilus, L. hominis, L. iners, and Bifidobacterium dentium. An unknown Lactobacillus species is associated with type IIa dyslipidemia and overweight, whereas Alloprevotella rava is associated with type IIb and IV dyslipidemias.DISCUSSION:Direct analysis of the duodenal microbiome has identified key genera associated with overweight and obesity, including some previously identified in stool, e.g., Bifidobacterium and Lactobacillus. Specific species and strains exhibit differing associations with overweight and obesity, including escalation and de-escalation features that may represent targets for future study and therapeutics. abstract-type="graphical">
Author Pimentel, Mark
Morales, Walter
Barlow, Gillian M.
Weitsman, Stacy
Hosseini, Ava
Rezaie, Ali
Parodi, Gonzalo
Leite, Gabriela
Cohrs, Daniel
Mathur, Ruchi
Rashid, Mohamad
Author_xml – sequence: 1
  givenname: Gabriela
  orcidid: 0000-0001-5772-7735
  surname: Leite
  fullname: Leite, Gabriela
  email: Gabriela.leite@cshs.org
  organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California
– sequence: 2
  givenname: Gillian M.
  orcidid: 0000-0002-0487-048X
  surname: Barlow
  fullname: Barlow, Gillian M.
  email: gillian.barlow@cshs.org
  organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California
– sequence: 3
  givenname: Mohamad
  orcidid: 0000-0002-1256-9478
  surname: Rashid
  fullname: Rashid, Mohamad
  email: mohamad.rashid@cshs.org
  organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California
– sequence: 4
  givenname: Ava
  orcidid: 0000-0002-1979-3034
  surname: Hosseini
  fullname: Hosseini, Ava
  email: Ava.Hosseini@cshs.org
  organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California
– sequence: 5
  givenname: Daniel
  orcidid: 0000-0002-9595-4856
  surname: Cohrs
  fullname: Cohrs, Daniel
  email: dcohrs3@gmail.com
  organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California
– sequence: 6
  givenname: Gonzalo
  surname: Parodi
  fullname: Parodi, Gonzalo
  email: Gonzalo.Parodi@cshs.org
  organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California
– sequence: 7
  givenname: Walter
  surname: Morales
  fullname: Morales, Walter
  email: Walter.Morales@cshs.org
  organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California
– sequence: 8
  givenname: Stacy
  orcidid: 0009-0006-7069-701X
  surname: Weitsman
  fullname: Weitsman, Stacy
  email: Stacy.weitsman@cshs.org
  organization: Medically Associated Science and Technology (MAST) Program, Cedars-Sinai, Los Angeles, California
– sequence: 9
  givenname: Ali
  orcidid: 0000-0002-0106-372X
  surname: Rezaie
  fullname: Rezaie, Ali
  email: ali.rezaie@cshs.org
  organization: Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai, Los Angeles, California
– sequence: 10
  givenname: Mark
  orcidid: 0000-0002-0619-5115
  surname: Pimentel
  fullname: Pimentel, Mark
  email: pimentelm@cshs.org
  organization: Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai, Los Angeles, California
– sequence: 11
  givenname: Ruchi
  orcidid: 0000-0003-1053-6557
  surname: Mathur
  fullname: Mathur, Ruchi
  organization: Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Cedars-Sinai, Los Angeles, California
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38578969$$D View this record in MEDLINE/PubMed
BookMark eNqFkU1vEzEQhi1URNPCTwBZ4sJli792HYtTCS1BKiqiII4rrzPuOnjXxfYmKgd-O6YpCOXSuYw0et7RaJ4jdDCGERB6TskJFZyo13p9fUL-KyYVeYRmtJasIkzQAzT7M60Uk-QQHaW0JoTWTNZP0CGf13KuGjVDvxa9jtpkiO6nzi6MOFice8BXg_Yevw1b8PijMzF0LgyAP8MGtE_4nbMWIowZf4rBOg8JuxEvp0GP-Grq1mBywt_6gE8j4MsNxC246z7jEPFSb8qog-Ty7VP02JZ18Oy-H6Ov52dfFsvq4vL9h8XpRWUEF6RqtBW1tivZSUaoscAMEZR3zKgVtRSsrnkjJShtuVJzYjppiQJVc0ObjhJ-jF7t9t7E8GOClNvBJQPe6xHClFpOuGBCNfOmoC_30HWY4liuK1QjiJKUskK9uKemboBVexPdoONt-_ezBah3QHldShHsP4SS9s5gWwy2-wZL7s1ezrh8ZyZH7fyDabVLb4MvTtN3P20htn1xlvsHsr8BlHeyEA
CitedBy_id crossref_primary_10_14309_ajg_0000000000002855
crossref_primary_10_14309_ajg_0000000000003071
crossref_primary_10_1080_19490976_2024_2405547
crossref_primary_10_1039_D4FO03049D
crossref_primary_10_3390_brainsci14080807
crossref_primary_10_1097_MD_0000000000041617
Cites_doi 10.1038/ismej.2009.112
10.1016/S2213-8587(18)30288-2
10.1038/ijo.2008.155
10.1016/j.copbio.2014.09.005
10.1038/s41598-022-05723-9
10.1007/s10620-020-06173-x
10.1016/j.jnutbio.2018.10.003
10.1038/nature05414
10.1155/2018/2037838
10.1097/GME.0000000000001917
10.1371/journal.pone.0009085
10.1186/s40168-021-01101-1
10.1016/j.celrep.2021.109765
10.1016/j.jcmgh.2019.07.006
10.1002/mnfr.202100639
10.1016/j.ebiom.2020.102766
10.3389/fnut.2019.00024
10.1038/nature11234
10.4093/dmj.2015.39.3.198
10.1038/4441022a
10.1136/gutjnl-2021-326158
10.1056/NEJMra1514009
10.1016/j.metabol.2023.155712
10.1038/nature12506
10.1038/s41418-022-01062-4
10.1371/journal.pcbi.1003531
10.1016/j.micpath.2012.05.007
10.1186/s40168-021-01162-2
10.4082/kjfm.2013.34.2.80
10.3390/jcm9020369
10.1111/j.1462-2920.2009.01941.x
10.1186/s40168-017-0237-y
10.1186/s12866-019-1617-1
10.1038/s41598-023-37720-x
10.1371/journal.pone.0178868
10.1016/j.cgh.2023.06.001
10.1186/s40168-022-01374-0
10.1056/NEJMoa1614362
10.1038/s41591-022-01688-4
10.1038/oby.2009.167
10.1016/j.pbj.2016.03.005
10.1038/nutd.2014.6
10.1038/ijo.2017.161
10.1016/j.soard.2020.04.008
10.1080/19490976.2023.2172671
10.1371/journal.pone.0137784
10.3390/microorganisms8111811
10.1093/nar/gks808
10.1016/0002-9149(90)91247-4
10.1126/scitranslmed.3000322
ContentType Journal Article
Copyright Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology
– notice: Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.
– notice: Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
DOI 10.14309/ajg.0000000000002790
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic

ProQuest One Academic Middle East (New)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1572-0241
EndPage 1153
ExternalDocumentID 38578969
10_14309_ajg_0000000000002790
AJG-23-2490
Genre research-article
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Monica Lester Charitable Trust
– fundername: Elias, Genevieve, and Georgianna Atol Charitable Trust
GroupedDBID ---
--K
-Q-
.55
.GJ
0R~
123
1B1
1OC
23M
31~
36B
39C
3O-
4.4
4G.
53G
5RE
5VS
6J9
70F
7X7
88E
8FI
8FJ
8GM
AAAAV
AAEDT
AAGIX
AAHPQ
AAIQE
AAJCS
AALRI
AAMOA
AAQFI
AAQKA
AAQQT
AAQXK
AASCR
AASXQ
AAXUO
ABASU
ABAWZ
ABDIG
ABJNI
ABLJU
ABOCM
ABPXF
ABUWG
ABVCZ
ABWVN
ABXYN
ABZZY
ACGFO
ACGFS
ACILI
ACKTT
ACLDA
ACNWC
ACOAL
ACRPL
ACXJB
ACXQS
ACZKN
ADBBV
ADFRT
ADGGA
ADHPY
ADMUD
ADNKB
ADNMO
ADSXY
AEBDS
AEETU
AENEX
AEXYK
AFBFQ
AFBPY
AFDTB
AFEBI
AFEXH
AFFNX
AFKRA
AFNMH
AFUWQ
AGAYW
AGQPQ
AHMBA
AHOMT
AHQNM
AHQVU
AHSBF
AHVBC
AI.
AINUH
AJAOE
AJCLO
AJIOK
AJNWD
AJRNO
AJZMW
AKCTQ
AKRWK
AKULP
ALIPV
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BENPR
BPHCQ
BVXVI
BYPQX
C45
CAG
CCPQU
COF
CS3
DIWNM
EBS
EE.
EEVPB
EJD
EMB
EMOBN
ERAAH
F5P
FCALG
FDB
FDQFY
FEDTE
FGOYB
FYUFA
GNXGY
GQDEL
HLJTE
HMCUK
HVGLF
HZ~
IHE
IKREB
IKYAY
IPNFZ
JSO
LH4
LW6
M1P
M41
N4W
NQ-
O9-
ODMTH
OPUJH
OVD
OVDNE
P0W
P2P
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
R2-
RIG
RLZ
RNT
RNTTT
ROL
RPZ
SEW
SJN
SSZ
SV3
TEORI
TSPGW
UDS
UKHRP
VH1
X7M
XIF
XPP
ZGI
ZXP
ZZMQN
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c4340-6af45afd7b7201cfe2c0413b2c9d1f1efa53677e9af39980cb7f09e953c16b103
IEDL.DBID 7X7
ISSN 0002-9270
1572-0241
IngestDate Mon Jul 21 09:46:28 EDT 2025
Sat Aug 23 12:23:51 EDT 2025
Mon Jul 21 06:05:39 EDT 2025
Thu Aug 07 06:52:30 EDT 2025
Thu Apr 24 22:52:25 EDT 2025
Mon Aug 04 20:40:26 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords biogenic amines metabolism
small intestinal microbiome
dyslipidemias
overweight
obesity
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of The American College of Gastroenterology.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4340-6af45afd7b7201cfe2c0413b2c9d1f1efa53677e9af39980cb7f09e953c16b103
Notes Correspondence: Ruchi Mathur, MD. E-mail: ruchi.mathur@cshs.org.SUPPLEMENTARY MATERIAL accompanies this paper at http://links.lww.com/AJG/D239.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0009-0006-7069-701X
0000-0002-0106-372X
0000-0002-1979-3034
0000-0002-0487-048X
0000-0002-1256-9478
0000-0002-9595-4856
0000-0001-5772-7735
0000-0002-0619-5115
0000-0003-1053-6557
0000-0002-0106-372
0009-0006-7069-701
0000-0002-0487-048
OpenAccessLink https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&DO=10.14309/ajg.0000000000002790
PMID 38578969
PQID 3064097112
PQPubID 2041977
PageCount 13
ParticipantIDs proquest_miscellaneous_3034249686
proquest_journals_3064097112
pubmed_primary_38578969
crossref_primary_10_14309_ajg_0000000000002790
crossref_citationtrail_10_14309_ajg_0000000000002790
wolterskluwer_health_10_14309_ajg_0000000000002790
PublicationCentury 2000
PublicationDate 2024-June
2024-06-00
2024-06-01
20240601
PublicationDateYYYYMMDD 2024-06-01
PublicationDate_xml – month: 06
  year: 2024
  text: 2024-June
PublicationDecade 2020
PublicationPlace Philadelphia, PA
PublicationPlace_xml – name: Philadelphia, PA
– name: United States
– name: New York
PublicationTitle The American journal of gastroenterology
PublicationTitleAbbrev Am J Gastroenterol
PublicationTitleAlternate Am J Gastroenterol
PublicationYear 2024
Publisher Wolters Kluwer
Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
Publisher_xml – name: Wolters Kluwer
– name: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
References Heymsfield, Wadden (R7) 2017; 376
Barlow, Lin, Mathur, Bagchi, Nair (R36) 2018
Hur, Lee (R12) 2015; 39
Gutierrez-Repiso, Moreno-Indias, Martin-Nunez (R52) 2020; 16
Fact Sheet-Obesity and Overweight. World Health Organization: Geneva, Switzerland, 2020.
Centers for Disease Control and Prevention. Overweight & Obesity. 2022. (https://www.cdc.gov/obesity/index.html). Accessed July 12, 2023.
LaRosa (R29) 1990; 65
Darra, Singh, Jena (R51) 2023; 13
Ley, Turnbaugh, Klein (R15) 2006; 444
Leite, Morales, Weitsman (R22) 2019; 19
Larabi, Masson, Bäumler (R44) 2023; 15
Larsen, Vogensen, van den Berg (R13) 2010; 5
Belizario, Faintuch, Garay-Malpartida (R10) 2018; 2018
Le Chatelier, Nielsen, Qin (R19) 2013; 500
Leser, Mølbak (R21) 2009; 11
Million, Angelakis, Paul (R45) 2012; 53
Leite, Rezaie, Mathur (R27) 2024; 22
(R9) 2012; 486
Angelakis, Armougom, Carriere (R56) 2015; 10
Duncan, Lobley, Holtrop (R18) 2008; 32
McMurdie, Holmes (R31) 2014; 10
Guzior, Quinn (R42) 2021; 9
Kastl, Terry, Wu (R37) 2020; 9
Hildebrandt, Ibrahim, Peltzer (R48) 2023; 30
Leite, Weitsman, Parodi (R24) 2020; 65
Ramos-Molina, Queipo-Ortuno, Lambertos (R49) 2019; 6
Afshin, Forouzanfar (R6) 2017; 377
Turnbaugh, Ley, Mahowald (R14) 2006; 444
Schwiertz, Taras, Schafer (R16) 2010; 18
Wu, Zhang, Ren (R35) 2017; 12
Weiss, Xu, Peddada (R32) 2017; 5
Kim, Yoon, Park (R46) 2022; 10
Sroka-Oleksiak, Mlodzinska, Bulanda (R54) 2020; 9
Centers for Disease Control and Prevention. Adult Obesity Facts. 2020. (https://www.cdc.gov/obesity/data/adult.html). Accessed July 12, 2023.
Leite, Pimentel, Barlow (R25) 2021; 36
El Aidy, van den Bogert, Kleerebezem (R20) 2015; 32
Klindworth, Pruesse, Schweer (R30) 2013; 41
Leite, Barlow, Parodi (R26) 2022; 29
Villmones, Svanevik, Ulvestad (R53) 2022; 12
National Cancer Institute. Obesity and Cancer. 2017. (https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet). Accessed July 12, 2023.
Shanahan, Kang, Staudacher (R57) 2023; 72
Zhang, Zhang, Wang (R17) 2010; 4
Crovesy, Ostrowski, Ferreira (R41) 2017; 41
Ma, Zheng, Ni (R47) 2022; 66
Centers for Disease Control and Prevention. Adult Obesity Causes & Consequences. 2021. (https://www.cdc.gov/obesity/adult/causes.html). Accessed July 12, 2023.
Fromentin, Forslund, Chechi (R34) 2022; 28
Granata, Nardelli, D'Argenio (R55) 2020; 8
Bhaskaran, Dos-Santos-Silva, Leon (R8) 2018; 6
(R28) 2021; 44
Barlow, Leite, Romano (R23) 2021; 9
Steinbach, Masi, Ribeiro (R50) 2024; 150
Rouxinol-Dias, Pinto, Janeiro (R38) 2016; 1
Wei, Huang, Zhao (R43) 2020; 55
Turnbaugh, Ridaura, Faith (R33) 2009; 1
Drissi, Merhej, Angelakis (R39) 2014; 4
Sharma, Tripathi (R11) 2019; 63
Jung, Lee, Kang (R40) 2013; 34
Zhang (R17-20250804) 2010; 4
Leite (R25-20250804) 2021; 36
LaRosa (R29-20250804) 1990; 65
Steinbach (R50-20250804) 2024; 150
Million (R45-20250804) 2012; 53
McMurdie (R31-20250804) 2014; 10
(R9-20250804) 2012; 486
Angelakis (R56-20250804) 2015; 10
Granata (R55-20250804) 2020; 8
Kim (R46-20250804) 2022; 10
Crovesy (R41-20250804) 2017; 41
Hur (R12-20250804) 2015; 39
Le Chatelier (R19-20250804) 2013; 500
Ley (R15-20250804) 2006; 444
Ramos-Molina (R49-20250804) 2019; 6
Leite (R26-20250804) 2022; 29
Wu (R35-20250804) 2017; 12
Heymsfield (R7-20250804) 2017; 376
Fromentin (R34-20250804) 2022; 28
Wei (R43-20250804) 2020; 55
Sroka-Oleksiak (R54-20250804) 2020; 9
Guzior (R42-20250804) 2021; 9
Rouxinol-Dias (R38-20250804) 2016; 1
Larsen (R13-20250804) 2010; 5
Leite (R22-20250804) 2019; 19
Larabi (R44-20250804) 2023; 15
Jung (R40-20250804) 2013; 34
Hildebrandt (R48-20250804) 2023; 30
Darra (R51-20250804) 2023; 13
(R28-20250804) 2021; 44
Schwiertz (R16-20250804) 2010; 18
Kastl (R37-20250804) 2020; 9
Afshin (R6-20250804) 2017; 377
Barlow (R23-20250804) 2021; 9
El Aidy (R20-20250804) 2015; 32
Leite (R27-20250804) 2024; 22
Leite (R24-20250804) 2020; 65
Turnbaugh (R33-20250804) 2009; 1
Bhaskaran (R8-20250804) 2018; 6
Villmones (R53-20250804) 2022; 12
Duncan (R18-20250804) 2008; 32
Gutierrez-Repiso (R52-20250804) 2020; 16
Belizario (R10-20250804) 2018; 2018
Drissi (R39-20250804) 2014; 4
Klindworth (R30-20250804) 2013; 41
Leser (R21-20250804) 2009; 11
Sharma (R11-20250804) 2019; 63
Shanahan (R57-20250804) 2023; 72
Weiss (R32-20250804) 2017; 5
Turnbaugh (R14-20250804) 2006; 444
Ma (R47-20250804) 2022; 66
References_xml – volume: 376
  start-page: 254
  issue: 3
  year: 2017
  end-page: 66
  ident: R7
  article-title: Mechanisms, pathophysiology, and management of obesity
  publication-title: N Engl J Med
– volume: 444
  start-page: 1022
  issue: 7122
  year: 2006
  end-page: 3
  ident: R15
  article-title: Microbial ecology: Human gut microbes associated with obesity
  publication-title: Nature
– volume: 39
  start-page: 198
  issue: 3
  year: 2015
  end-page: 203
  ident: R12
  article-title: Gut microbiota and metabolic disorders
  publication-title: Diabetes Metab J
– volume: 4
  start-page: 232
  issue: 2
  year: 2010
  end-page: 41
  ident: R17
  article-title: Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice
  publication-title: ISME J
– volume: 9
  start-page: 214
  issue: 1
  year: 2021
  ident: R23
  article-title: Quantitative sequencing clarifies the role of disruptor taxa, oral microbiota, and strict anaerobes in the human small-intestine microbiome
  publication-title: Microbiome
– volume: 444
  start-page: 1027
  issue: 7122
  year: 2006
  end-page: 31
  ident: R14
  article-title: An obesity-associated gut microbiome with increased capacity for energy harvest
  publication-title: Nature
– volume: 16
  start-page: 1575
  issue: 10
  year: 2020
  end-page: 85
  ident: R52
  article-title: Mucosa-associated microbiota in the jejunum of patients with morbid obesity: Alterations in states of insulin resistance and metformin treatment
  publication-title: Surg Obes Relat Dis
– volume: 29
  start-page: 264
  issue: 3
  year: 2022
  end-page: 75
  ident: R26
  article-title: Duodenal microbiome changes in postmenopausal women: Effects of hormone therapy and implications for cardiovascular risk
  publication-title: Menopause
– volume: 30
  start-page: 279
  issue: 2
  year: 2023
  end-page: 92
  ident: R48
  article-title: Cell death and inflammation during obesity: "Know my methods, WAT(son)"
  publication-title: Cell Death Different
– volume: 486
  start-page: 207
  issue: 7402
  year: 2012
  end-page: 14
  ident: R9
  article-title: Structure, function and diversity of the healthy human microbiome
  publication-title: Nature
– volume: 5
  start-page: e9085
  year: 2010
  ident: R13
  article-title: Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults
  publication-title: PLoS One
– volume: 41
  start-page: e1
  issue: 1
  year: 2013
  ident: R30
  article-title: Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies
  publication-title: Nucleic Acids Res
– volume: 4
  start-page: e109
  issue: 2
  year: 2014
  ident: R39
  article-title: Comparative genomics analysis of Lactobacillus species associated with weight gain or weight protection
  publication-title: Nutr Diabetes
– volume: 41
  start-page: 1607
  issue: 11
  year: 2017
  end-page: 14
  ident: R41
  article-title: Effect of Lactobacillus on body weight and body fat in overweight subjects: A systematic review of randomized controlled clinical trials
  publication-title: Int J Obes
– volume: 9
  start-page: 369
  year: 2020
  ident: R54
  article-title: Metagenomic analysis of duodenal microbiota reveals a potential biomarker of dysbiosis in the course of obesity and type 2 diabetes: A pilot study
  publication-title: J Clin Med
– volume: 12
  start-page: e0178868
  issue: 6
  year: 2017
  ident: R35
  article-title: Effect of probiotic Lactobacillus on lipid profile: A systematic review and meta-analysis of randomized, controlled trials
  publication-title: PLoS One
– volume: 66
  start-page: e2100639
  issue: 3
  year: 2022
  ident: R47
  article-title: Bifidobacterium animalis subsp. lactis lkm512 attenuates obesity-associated inflammation and insulin resistance through the modification of gut microbiota in high-fat diet-induced obese mice
  publication-title: Mol Nutr Food Res
– volume: 13
  start-page: 11038
  issue: 1
  year: 2023
  ident: R51
  article-title: Hyperglycemia is associated with duodenal dysbiosis and altered duodenal microenvironment
  publication-title: Sci Rep
– volume: 12
  start-page: 1682
  issue: 1
  year: 2022
  ident: R53
  article-title: Investigating the human jejunal microbiota
  publication-title: Sci Rep
– reference: Fact Sheet-Obesity and Overweight. World Health Organization: Geneva, Switzerland, 2020.
– volume: 65
  start-page: 7f
  issue: 12
  year: 1990
  end-page: 10f
  ident: R29
  article-title: At what levels of total low- or high-density lipoprotein cholesterol should diet/drug therapy be initiated? United States guidelines
  publication-title: Am J Cardiol
– start-page: 65
  year: 2018
  end-page: 91
  ident: R36
  article-title: An overview of the roles of the gut microbiome in obesity and diabetes
  publication-title: Nutritional and Therapeutic Interventions for Diabetes and Metabolic Syndrome
– volume: 1
  start-page: 6ra14
  issue: 6
  year: 2009
  ident: R33
  article-title: The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice
  publication-title: Sci Transl Med
– volume: 63
  start-page: 101
  year: 2019
  end-page: 8
  ident: R11
  article-title: Gut microbiome and type 2 diabetes: Where we are and where to go?
  publication-title: J Nutr Biochem
– volume: 53
  start-page: 100
  issue: 2
  year: 2012
  end-page: 8
  ident: R45
  article-title: Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals
  publication-title: Microb Pathog
– volume: 18
  start-page: 190
  issue: 1
  year: 2010
  end-page: 5
  ident: R16
  article-title: Microbiota and SCFA in lean and overweight healthy subjects
  publication-title: Obesity (Silver Spring)
– volume: 9
  start-page: 33
  issue: 1
  year: 2020
  end-page: 45
  ident: R37
  article-title: The structure and function of the human small intestinal microbiota: Current understanding and future directions
  publication-title: Cell Mol Gastroenterol Hepatol
– volume: 15
  start-page: 2172671
  issue: 1
  year: 2023
  ident: R44
  article-title: Bile acids as modulators of gut microbiota composition and function
  publication-title: Gut Microbes
– volume: 65
  start-page: 2595
  issue: 9
  year: 2020
  end-page: 604
  ident: R24
  article-title: Mapping the segmental microbiomes in the human small bowel in comparison with stool: A REIMAGINE study
  publication-title: Dig Dis Sci
– volume: 36
  start-page: 109765
  issue: 13
  year: 2021
  ident: R25
  article-title: Age and the aging process significantly alter the small bowel microbiome
  publication-title: Cell Rep
– volume: 22
  start-page: 259
  issue: 2
  year: 2024
  end-page: 70
  ident: R27
  article-title: Defining small intestinal bacterial overgrowth by culture and high throughput sequencing
  publication-title: Clin Gastroenterol Hepatol
– volume: 5
  start-page: 27
  issue: 1
  year: 2017
  ident: R32
  article-title: Normalization and microbial differential abundance strategies depend upon data characteristics
  publication-title: Microbiome
– volume: 44
  start-page: S15
  issue: Suppl 1
  year: 2021
  end-page: 33
  ident: R28
  article-title: 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021
  publication-title: Diabetes Care
– volume: 6
  start-page: 24
  year: 2019
  ident: R49
  article-title: Dietary and gut microbiota polyamines in obesity- and age-related diseases
  publication-title: Front Nutr
– volume: 2018
  start-page: 2037838
  year: 2018
  ident: R10
  article-title: Gut microbiome dysbiosis and immunometabolism: New frontiers for treatment of metabolic diseases
  publication-title: Mediators Inflamm
– volume: 10
  start-page: e0137784
  issue: 9
  year: 2015
  ident: R56
  article-title: A metagenomic investigation of the duodenal microbiota reveals links with obesity
  publication-title: PLoS One
– volume: 72
  start-page: 929
  issue: 5
  year: 2023
  end-page: 38
  ident: R57
  article-title: Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia
  publication-title: Gut
– reference: Centers for Disease Control and Prevention. Adult Obesity Causes & Consequences. 2021. (https://www.cdc.gov/obesity/adult/causes.html). Accessed July 12, 2023.
– volume: 1
  start-page: 12
  year: 2016
  end-page: 24
  ident: R38
  article-title: Probiotics for the control of obesity: Its effect on weight change
  publication-title: Porto Biomed J
– reference: Centers for Disease Control and Prevention. Overweight & Obesity. 2022. (https://www.cdc.gov/obesity/index.html). Accessed July 12, 2023.
– volume: 32
  start-page: 14
  year: 2015
  end-page: 20
  ident: R20
  article-title: The small intestine microbiota, nutritional modulation and relevance for health
  publication-title: Curr Opin Biotechnol
– volume: 55
  start-page: 102766
  year: 2020
  ident: R43
  article-title: A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
  publication-title: EBioMedicine
– volume: 11
  start-page: 2194
  issue: 9
  year: 2009
  end-page: 206
  ident: R21
  article-title: Better living through microbial action: The benefits of the mammalian gastrointestinal microbiota on the host
  publication-title: Environ Microbiol
– volume: 28
  start-page: 303
  issue: 2
  year: 2022
  end-page: 14
  ident: R34
  article-title: Microbiome and metabolome features of the cardiometabolic disease spectrum
  publication-title: Nat Med
– volume: 6
  start-page: 944
  issue: 12
  year: 2018
  end-page: 53
  ident: R8
  article-title: Association of BMI with overall and cause-specific mortality: A population-based cohort study of 3·6 million adults in the UK
  publication-title: Lancet Diabetes Endocrinol
– volume: 32
  start-page: 1720
  issue: 11
  year: 2008
  end-page: 4
  ident: R18
  article-title: Human colonic microbiota associated with diet, obesity and weight loss
  publication-title: Int J Obes (Lond)
– volume: 500
  start-page: 541
  issue: 7464
  year: 2013
  end-page: 6
  ident: R19
  article-title: Richness of human gut microbiome correlates with metabolic markers
  publication-title: Nature
– volume: 8
  start-page: 1811
  issue: 11
  year: 2020
  ident: R55
  article-title: Duodenal metatranscriptomics to define human and microbial functional alterations associated with severe obesity: A pilot study
  publication-title: Microorganisms
– volume: 10
  start-page: e1003531
  issue: 4
  year: 2014
  ident: R31
  article-title: Waste not, want not: Why rarefying microbiome data is inadmissible
  publication-title: PLoS Comput Biol
– volume: 19
  start-page: 239
  issue: 1
  year: 2019
  ident: R22
  article-title: Optimizing microbiome sequencing for small intestinal aspirates: Validation of novel techniques through the REIMAGINE study
  publication-title: BMC Microbiol
– volume: 377
  start-page: 13
  issue: 1
  year: 2017
  end-page: 27
  ident: R6
  article-title: Health effects of overweight and obesity in 195 countries over 25 years
  publication-title: N Engl J Med
– volume: 10
  start-page: 188
  issue: 1
  year: 2022
  ident: R46
  article-title: Bifidobacterial carbohydrate/nucleoside metabolism enhances oxidative phosphorylation in white adipose tissue to protect against diet-induced obesity
  publication-title: Microbiome
– volume: 34
  start-page: 80
  issue: 2
  year: 2013
  end-page: 9
  ident: R40
  article-title: Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: A randomized, double-blind clinical trial
  publication-title: Korean J Fam Med
– reference: National Cancer Institute. Obesity and Cancer. 2017. (https://www.cancer.gov/about-cancer/causes-prevention/risk/obesity/obesity-fact-sheet). Accessed July 12, 2023.
– volume: 9
  start-page: 140
  issue: 1
  year: 2021
  ident: R42
  article-title: Review: Microbial transformations of human bile acids
  publication-title: Microbiome
– volume: 150
  start-page: 155712
  year: 2024
  ident: R50
  article-title: Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation
  publication-title: Metabolism
– reference: Centers for Disease Control and Prevention. Adult Obesity Facts. 2020. (https://www.cdc.gov/obesity/data/adult.html). Accessed July 12, 2023.
– volume: 4
  start-page: 232
  issue: 2
  year: 2010
  ident: R17-20250804
  article-title: Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice
  publication-title: ISME J
  doi: 10.1038/ismej.2009.112
– volume: 6
  start-page: 944
  issue: 12
  year: 2018
  ident: R8-20250804
  article-title: Association of BMI with overall and cause-specific mortality: A population-based cohort study of 3·6 million adults in the UK
  publication-title: Lancet Diabetes Endocrinol
  doi: 10.1016/S2213-8587(18)30288-2
– volume: 32
  start-page: 1720
  issue: 11
  year: 2008
  ident: R18-20250804
  article-title: Human colonic microbiota associated with diet, obesity and weight loss
  publication-title: Int J Obes (Lond)
  doi: 10.1038/ijo.2008.155
– volume: 32
  start-page: 14
  year: 2015
  ident: R20-20250804
  article-title: The small intestine microbiota, nutritional modulation and relevance for health
  publication-title: Curr Opin Biotechnol
  doi: 10.1016/j.copbio.2014.09.005
– volume: 12
  start-page: 1682
  issue: 1
  year: 2022
  ident: R53-20250804
  article-title: Investigating the human jejunal microbiota
  publication-title: Sci Rep
  doi: 10.1038/s41598-022-05723-9
– volume: 65
  start-page: 2595
  issue: 9
  year: 2020
  ident: R24-20250804
  article-title: Mapping the segmental microbiomes in the human small bowel in comparison with stool: A REIMAGINE study
  publication-title: Dig Dis Sci
  doi: 10.1007/s10620-020-06173-x
– volume: 63
  start-page: 101
  year: 2019
  ident: R11-20250804
  article-title: Gut microbiome and type 2 diabetes: Where we are and where to go?
  publication-title: J Nutr Biochem
  doi: 10.1016/j.jnutbio.2018.10.003
– volume: 444
  start-page: 1027
  issue: 7122
  year: 2006
  ident: R14-20250804
  article-title: An obesity-associated gut microbiome with increased capacity for energy harvest
  publication-title: Nature
  doi: 10.1038/nature05414
– volume: 2018
  start-page: 2037838
  year: 2018
  ident: R10-20250804
  article-title: Gut microbiome dysbiosis and immunometabolism: New frontiers for treatment of metabolic diseases
  publication-title: Mediators Inflamm
  doi: 10.1155/2018/2037838
– volume: 29
  start-page: 264
  issue: 3
  year: 2022
  ident: R26-20250804
  article-title: Duodenal microbiome changes in postmenopausal women: Effects of hormone therapy and implications for cardiovascular risk
  publication-title: Menopause
  doi: 10.1097/GME.0000000000001917
– volume: 5
  start-page: e9085
  year: 2010
  ident: R13-20250804
  article-title: Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0009085
– volume: 9
  start-page: 140
  issue: 1
  year: 2021
  ident: R42-20250804
  article-title: Review: Microbial transformations of human bile acids
  publication-title: Microbiome
  doi: 10.1186/s40168-021-01101-1
– volume: 36
  start-page: 109765
  issue: 13
  year: 2021
  ident: R25-20250804
  article-title: Age and the aging process significantly alter the small bowel microbiome
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2021.109765
– volume: 9
  start-page: 33
  issue: 1
  year: 2020
  ident: R37-20250804
  article-title: The structure and function of the human small intestinal microbiota: Current understanding and future directions
  publication-title: Cell Mol Gastroenterol Hepatol
  doi: 10.1016/j.jcmgh.2019.07.006
– volume: 66
  start-page: e2100639
  issue: 3
  year: 2022
  ident: R47-20250804
  article-title: Bifidobacterium animalis subsp. lactis lkm512 attenuates obesity-associated inflammation and insulin resistance through the modification of gut microbiota in high-fat diet-induced obese mice
  publication-title: Mol Nutr Food Res
  doi: 10.1002/mnfr.202100639
– volume: 55
  start-page: 102766
  year: 2020
  ident: R43-20250804
  article-title: A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2020.102766
– volume: 6
  start-page: 24
  year: 2019
  ident: R49-20250804
  article-title: Dietary and gut microbiota polyamines in obesity- and age-related diseases
  publication-title: Front Nutr
  doi: 10.3389/fnut.2019.00024
– volume: 486
  start-page: 207
  issue: 7402
  year: 2012
  ident: R9-20250804
  article-title: Structure, function and diversity of the healthy human microbiome
  publication-title: Nature
  doi: 10.1038/nature11234
– volume: 39
  start-page: 198
  issue: 3
  year: 2015
  ident: R12-20250804
  article-title: Gut microbiota and metabolic disorders
  publication-title: Diabetes Metab J
  doi: 10.4093/dmj.2015.39.3.198
– volume: 444
  start-page: 1022
  issue: 7122
  year: 2006
  ident: R15-20250804
  article-title: Microbial ecology: Human gut microbes associated with obesity
  publication-title: Nature
  doi: 10.1038/4441022a
– volume: 72
  start-page: 929
  issue: 5
  year: 2023
  ident: R57-20250804
  article-title: Alterations to the duodenal microbiota are linked to gastric emptying and symptoms in functional dyspepsia
  publication-title: Gut
  doi: 10.1136/gutjnl-2021-326158
– volume: 376
  start-page: 254
  issue: 3
  year: 2017
  ident: R7-20250804
  article-title: Mechanisms, pathophysiology, and management of obesity
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1514009
– volume: 150
  start-page: 155712
  year: 2024
  ident: R50-20250804
  article-title: Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation
  publication-title: Metabolism
  doi: 10.1016/j.metabol.2023.155712
– volume: 500
  start-page: 541
  issue: 7464
  year: 2013
  ident: R19-20250804
  article-title: Richness of human gut microbiome correlates with metabolic markers
  publication-title: Nature
  doi: 10.1038/nature12506
– volume: 30
  start-page: 279
  issue: 2
  year: 2023
  ident: R48-20250804
  article-title: Cell death and inflammation during obesity: “Know my methods, WAT(son)”
  publication-title: Cell Death Different
  doi: 10.1038/s41418-022-01062-4
– volume: 10
  start-page: e1003531
  issue: 4
  year: 2014
  ident: R31-20250804
  article-title: Waste not, want not: Why rarefying microbiome data is inadmissible
  publication-title: PLoS Comput Biol
  doi: 10.1371/journal.pcbi.1003531
– volume: 53
  start-page: 100
  issue: 2
  year: 2012
  ident: R45-20250804
  article-title: Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals
  publication-title: Microb Pathog
  doi: 10.1016/j.micpath.2012.05.007
– volume: 9
  start-page: 214
  issue: 1
  year: 2021
  ident: R23-20250804
  article-title: Quantitative sequencing clarifies the role of disruptor taxa, oral microbiota, and strict anaerobes in the human small-intestine microbiome
  publication-title: Microbiome
  doi: 10.1186/s40168-021-01162-2
– volume: 34
  start-page: 80
  issue: 2
  year: 2013
  ident: R40-20250804
  article-title: Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: A randomized, double-blind clinical trial
  publication-title: Korean J Fam Med
  doi: 10.4082/kjfm.2013.34.2.80
– volume: 9
  start-page: 369
  year: 2020
  ident: R54-20250804
  article-title: Metagenomic analysis of duodenal microbiota reveals a potential biomarker of dysbiosis in the course of obesity and type 2 diabetes: A pilot study
  publication-title: J Clin Med
  doi: 10.3390/jcm9020369
– volume: 11
  start-page: 2194
  issue: 9
  year: 2009
  ident: R21-20250804
  article-title: Better living through microbial action: The benefits of the mammalian gastrointestinal microbiota on the host
  publication-title: Environ Microbiol
  doi: 10.1111/j.1462-2920.2009.01941.x
– volume: 5
  start-page: 27
  issue: 1
  year: 2017
  ident: R32-20250804
  article-title: Normalization and microbial differential abundance strategies depend upon data characteristics
  publication-title: Microbiome
  doi: 10.1186/s40168-017-0237-y
– volume: 19
  start-page: 239
  issue: 1
  year: 2019
  ident: R22-20250804
  article-title: Optimizing microbiome sequencing for small intestinal aspirates: Validation of novel techniques through the REIMAGINE study
  publication-title: BMC Microbiol
  doi: 10.1186/s12866-019-1617-1
– volume: 13
  start-page: 11038
  issue: 1
  year: 2023
  ident: R51-20250804
  article-title: Hyperglycemia is associated with duodenal dysbiosis and altered duodenal microenvironment
  publication-title: Sci Rep
  doi: 10.1038/s41598-023-37720-x
– volume: 12
  start-page: e0178868
  issue: 6
  year: 2017
  ident: R35-20250804
  article-title: Effect of probiotic Lactobacillus on lipid profile: A systematic review and meta-analysis of randomized, controlled trials
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0178868
– volume: 22
  start-page: 259
  issue: 2
  year: 2024
  ident: R27-20250804
  article-title: Defining small intestinal bacterial overgrowth by culture and high throughput sequencing
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2023.06.001
– volume: 10
  start-page: 188
  issue: 1
  year: 2022
  ident: R46-20250804
  article-title: Bifidobacterial carbohydrate/nucleoside metabolism enhances oxidative phosphorylation in white adipose tissue to protect against diet-induced obesity
  publication-title: Microbiome
  doi: 10.1186/s40168-022-01374-0
– volume: 377
  start-page: 13
  issue: 1
  year: 2017
  ident: R6-20250804
  article-title: Health effects of overweight and obesity in 195 countries over 25 years
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1614362
– volume: 28
  start-page: 303
  issue: 2
  year: 2022
  ident: R34-20250804
  article-title: Microbiome and metabolome features of the cardiometabolic disease spectrum
  publication-title: Nat Med
  doi: 10.1038/s41591-022-01688-4
– volume: 18
  start-page: 190
  issue: 1
  year: 2010
  ident: R16-20250804
  article-title: Microbiota and SCFA in lean and overweight healthy subjects
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2009.167
– volume: 1
  start-page: 12
  year: 2016
  ident: R38-20250804
  article-title: Probiotics for the control of obesity: Its effect on weight change
  publication-title: Porto Biomed J
  doi: 10.1016/j.pbj.2016.03.005
– volume: 4
  start-page: e109
  issue: 2
  year: 2014
  ident: R39-20250804
  article-title: Comparative genomics analysis of Lactobacillus species associated with weight gain or weight protection
  publication-title: Nutr Diabetes
  doi: 10.1038/nutd.2014.6
– volume: 41
  start-page: 1607
  issue: 11
  year: 2017
  ident: R41-20250804
  article-title: Effect of Lactobacillus on body weight and body fat in overweight subjects: A systematic review of randomized controlled clinical trials
  publication-title: Int J Obes
  doi: 10.1038/ijo.2017.161
– volume: 16
  start-page: 1575
  issue: 10
  year: 2020
  ident: R52-20250804
  article-title: Mucosa-associated microbiota in the jejunum of patients with morbid obesity: Alterations in states of insulin resistance and metformin treatment
  publication-title: Surg Obes Relat Dis
  doi: 10.1016/j.soard.2020.04.008
– volume: 44
  start-page: S15
  issue: Suppl 1
  year: 2021
  ident: R28-20250804
  article-title: 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2021
  publication-title: Diabetes Care
– volume: 15
  start-page: 2172671
  issue: 1
  year: 2023
  ident: R44-20250804
  article-title: Bile acids as modulators of gut microbiota composition and function
  publication-title: Gut Microbes
  doi: 10.1080/19490976.2023.2172671
– volume: 10
  start-page: e0137784
  issue: 9
  year: 2015
  ident: R56-20250804
  article-title: A metagenomic investigation of the duodenal microbiota reveals links with obesity
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0137784
– volume: 8
  start-page: 1811
  issue: 11
  year: 2020
  ident: R55-20250804
  article-title: Duodenal metatranscriptomics to define human and microbial functional alterations associated with severe obesity: A pilot study
  publication-title: Microorganisms
  doi: 10.3390/microorganisms8111811
– volume: 41
  start-page: e1
  issue: 1
  year: 2013
  ident: R30-20250804
  article-title: Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gks808
– volume: 65
  start-page: 7f
  issue: 12
  year: 1990
  ident: R29-20250804
  article-title: At what levels of total low- or high-density lipoprotein cholesterol should diet/drug therapy be initiated? United States guidelines
  publication-title: Am J Cardiol
  doi: 10.1016/0002-9149(90)91247-4
– volume: 1
  start-page: 6ra14
  issue: 6
  year: 2009
  ident: R33-20250804
  article-title: The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.3000322
SSID ssj0015275
Score 2.4802973
Snippet INTRODUCTION:Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum...
Gut microbiome changes are linked to obesity, but findings are based on stool data. In this article, we analyzed the duodenal microbiome and serum biomarkers...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1141
SubjectTerms Adult
Aged
Antibiotics
Bifidobacterium - isolation & purification
Biomarkers - blood
Body mass index
Diabetes
Duodenum - microbiology
Female
Gastrointestinal Microbiome
Gastrointestinal surgery
Genomics
Glucagon
Humans
Lactobacillus - isolation & purification
Male
Metabolism
Middle Aged
Obesity
Obesity - microbiology
Overweight
Overweight - microbiology
Peptides
RNA, Ribosomal, 16S - genetics
Small intestine
Taxonomy
Triglycerides
Weight control
Title Characterization of the Small Bowel Microbiome Reveals Different Profiles in Human Subjects Who Are Overweight or Have Obesity
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&DO=10.14309/ajg.0000000000002790
https://www.ncbi.nlm.nih.gov/pubmed/38578969
https://www.proquest.com/docview/3064097112
https://www.proquest.com/docview/3034249686
Volume 119
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dT9UwFD9RSIzGGL_AIZKa-DrZ1m5dnwwg5EZykVwl3Ldl61oFLxuyC7zxt3vO2jtRE9zLkm1Nm5329Hc--jsA7wyXuZVxHCaJjkKRl3mYWy5CURl8rtM074nnxwfZ6Eh8mqZT73DrfFrlQif2irpuNfnINwkpE99RnHw4_xlS1SiKrvoSGvdhmajLKKVLTgeDiyq2pgv4qxIZ-RM8gkdqszz95rgL_ZVIUsu396Z_AOcjeHzdUgy7-9GnsN_aiPaewhOPINmWE_kzuGea5_Bg7GPkL-BmZ-BgdkcsWWsZwjz25ayczdh2e21mbHziCJjODJuYKwSLHfvoS6XM2aGr492xk4b1Tn6G6oX8NR07_t5iz4Z97vOpybBn7QUblVf4yJUYeAlHe7tfd0ahr7IQasEp97-0Ii1tLSuJYEBbg0LDna1KtKpjGxtbpjyT0qjSIpjJI11JGymjUq7jrIojvgJLTduYV8BqK4jBTaVGIczSUa55YlSdGWwmua0CEIv_W2hPQU6VMGYFmSIklgLFUvwtlgDeD83OHQfH_xqsL4RX-CXZFb8nUABvh9e4mChCUjamvaRvuEB7NMuzAFad0IceeY7KTWUqgOSPWVC4A6t3j2jt7hG9hocJgiWXgrYOS_OLS_MGwc682uhn9AYsb-1Pjvfxvr17cDj5BRbp-lw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrcRDCPEmUMBIcAxNbCeODwjRl7a0u1SlFb2FxLGhsE1Ks-2KCz-pv7HjOAkFpHJqjk6cWJnxzDeeF8BLzURiRBj6lKrA50mW-Ilh3Oe5xnEVRUlTeH40joe7_P1etDcHp10ujA2r7GRiI6iLStkz8kWLlG29o5C-Pfzh265R1rvatdBwbLGhf87QZKvfrK8gfV9Rura6szz0264CvuLMxrpnhkeZKUQuUPkpo3GRKMlzqmQRmlCbLGKxEFpmBpV3EqhcmEBqGTEVxnkYMHzvFZjnDE2ZAcwvrY63tnu_RURF1AFuSUXQ5gxxFsjF7NsXVy2xvaiwiuC8NvwH4t6Am7PKes3r703Q_DnVt3YbbrWYlbxzTHYH5nR5F66OWq_8Pfi13Fd9dkmdpDIEgSX5eJBNJmSpmukJGe27kk8HmmzrE4SnNVlpm7NMyZbrHF6T_ZI0bgWCAs2eENXk09cKv6zJhyaC2x4lkOqIDLMTHHJNDe7D7qVQ4AEMyqrUj4AUhtuacTLSEoGdChLFqJZFrHGaYCb3gHf_N1Vt0XPbe2OSWuPHkiVFsqR_k8WD1_20Q1f1438TFjripa0QqNPfLOvBi_42bl_rk8lKXR3bZxhHCzhOYg8eOqL3X2QJilMZSw_oH1yQuhTZi1f0-OIVPYdrw53RZrq5Pt54AtcpQjUXALcAg-nRsX6KUGuaP2v5m8Dny95SZ9X0NWU
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9QwDLfGkCYQQvzbKAwIEjyWa5O0aR4Qgh2nG-PGBEzcW2nTBLbd2rHeduKFD8anw2naMkAaT-tj2jRR7Ng_x44N8EQzkRgRhj6lKvB5kiV-Yhj3ea6xXUVR0iSen2zH413-ZhpNl-BndxfGhlV2MrER1EWl7Bn5wCJlm-8opAPThkXsDEcvjr75toKU9bR25TQci2zp7ws03-rnm0Ok9VNKR68_boz9tsKArzizce-Z4VFmCpELVITKaJwwSvWcKlmEJtQmi1gshJaZQUWeBCoXJpBaRkyFcR4GDP97CS4LFoV2j4lpb-zZarFRB70lFUF7e4izQA6y_S8ub2L7UGFVwlm9-A_YvQrXFpX1n9cHTfj8GSU4ugHXW_RKXjp2uwlLurwFK5PWP38bfmz0-Z_d9U5SGYIQk3w4zGYz8qpa6BmZ7LnkT4eavNenCFRrMmzLtMzJjqshXpO9kjQOBoKizZ4V1eTT1wpH1uRdE8ttDxVIdUzG2Sk2ufIGd2D3QtZ_FZbLqtR3gRSG2-xxMtISIZ4KEsWolkWssZtgJveAd-ubqjb9ua3CMUutGWTJkiJZ0r_J4sGzvtuRy__xvw7rHfHSVhzU6W_m9eBx_xo3svXOZKWuTuw3jKMtHCexB2uO6P2ILEHBKmPpAf2DC1J3Wfb8Gd07f0aPYAU3Uvp2c3vrPlyhiNlcJNw6LM-PT_QDxFzz_GHD3AQ-X_Ru-gUdyjg1
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+the+Small+Bowel+Microbiome+Reveals+Different+Profiles+in+Human+Subjects+Who+Are+Overweight+or+Have+Obesity&rft.jtitle=The+American+journal+of+gastroenterology&rft.au=Leite%2C+Gabriela&rft.au=Barlow%2C+Gillian+M&rft.au=Rashid+Mohamad&rft.au=Hosseini+Ava&rft.date=2024-06-01&rft.pub=Wolters+Kluwer+Health+Medical+Research%2C+Lippincott+Williams+%26+Wilkins&rft.issn=0002-9270&rft.eissn=1572-0241&rft.volume=119&rft.issue=6&rft.spage=1141&rft.epage=1153&rft_id=info:doi/10.14309%2Fajg.0000000000002790&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9270&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9270&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9270&client=summon